Polymerase chain reaction haplotyping using 3' mismatches in the forward and reverse primers: Application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin α

Tissue Antigens

Volumn 50, Issue 1, 1997, Pages 23-31

  Fanning, G C ^a,c   Bunce, M ^a   Black, C M ^b   Welsh, K I ^a  

^a Oxford Transplant Centre   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Genotyping; Haplotyping; Lymphotoxin; Polymerase chain reaction; Polymorphism; Tumor necrosis factor

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LYMPHOTOXIN; PRIMER DNA; TUMOR NECROSIS FACTOR;

ALLELE; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; METHODOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0031008262     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02829.x     Document Type: Article

References (24)

1. Dunham I, Sargent CA, Trowsdale, J, Campbell RD. Molecular mapping of the major histocompatibility complex by pulse-field gel electrophoresis. Proc Natl Acad Sci U S A 1987: 84: 7237-41.
2. Carroll MC, Katzman P, Alicot EM et al. Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci U S A 1987: 84: 8535-9.
3. Messer G, Spengler U, Jung MC et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlated with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991: 173: 177-86.
4. Partanen JK, S. Low degree of DNA polymorphism in the HLA-linked lymphotoxin (tumor necrosis factor beta) gene. Scand J Immunol 1988: 28: 313-6.
5. Abraham LJ, Marley JV, Nedospasov SA et al. Microsatellite, restriction fragment-length polymorphism, and sequence specific oligonucleotide typing of the tumor necrosis factor region. Hum Immunol 1993: 38: 17-23.
6. Ferencik S, Lindemann M, Horsthemke B, Grosse-Wilde H. A new restriction fragment length polymorphism of the human TNF-B gene detected by AspHI digest. Eur J Immunol 1992: 19: 425-30.
7. D'Alfonso SRPM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994: 39: 150-4.
8. Wilson AG, de Vries N, Pocoit F, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993: 177: 557-60.
9. Bouma G, Xia B, Crusius JBA et al. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1996: 103: 391-6.
10. Verjans GM, Brinkman BMN, Van Doornik CEM, Kijlstra A, Verweij CL. Polymorphism of tumor necrosis factor-alpha at position - 308 in relation to ankylosing spondylitis. Clin Exp Immunol 1994: 97: 45-7.
11. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993: 16: 180-6.
12. Bunce M, Welsh KI. Rapid DNA typing for HLA-C using sequence specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens 1994: 43: 7-17.
13. Bunce M, Barnardo MCNM, Procter J, Marsh SGE, Vilches C, Welsh KI. High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and comparison with serology. Tissue Antigens 1996: 48: 680-91.
14. Iris F, Bougueleret L, Prieur S et al. Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment. Nature Genet 1993: 3: 137-45.
15. Newton CR, Graham A, Heptinstall LE et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989: 17: 2503-16.
16. Bunce M, O'Neill CM, Barnardo MCNM et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995: 46: 355-67.
17. D'Alfonso SMP. A new polymorphism in the TNFA gene (abstract). Hum Immunol 1996: 47: 65.
18. Crusius JBA, Bing X, Mulder CJJ, Mearin ML, Pena AS. Relevance of haplotypes in the TNF region in celiac disease. Eur Cytokine Net 1994: 5: 168.
19. Zimmerman P, Hunter J, Bailey E, Nielson J, Nutman T. Tumor necrosis factor alpha promoter mutation frequencies among four North American racial groups. Hum Immunol 1996: 49(S1): 52.
20. Brinkman MNB, Huizinga TWJ, Breedveld FC, Verweij CL. Allele-specific quantification of TNF alpha transcripts in rheumatoid arthritis. Arthritis Rheum 1996: 39 (9 (suppl)): S224.
21. Badenhoop K, Schwarz G, Trowsdale J, Lewis V, Gale EAM, Botazzo, GF. TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989: 32: 345.
22. Dawkins RL, Leaver A, Cameron PU, Martin E, Kay PH, Christiansen FT. Some disease-associated ancestral haplotypes carry a polymorphism of TNF. Hum Immunol 1989: 26: 91.
23. Fugger L, Mosrling N, Ryder LP et al. NcoI restriction fragment polymorphism (RFLP) of tumor necrosis factor region in primary biliary cirrhosis and healthy Danes. Scand J Immunol 1989: 28: 313.
24. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 1995: 211(3): 833-9.